News
Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial...
Albumedix Ltd., the world leader in recombinant human albumin (rAlb), announced the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief...
News
Sygnature expands capabilities with acquisition of Alderley Oncology
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquisition of Alderley...
News
Messe Frankfurt to focus on highlighting strong anti-counterfeiting measures...
As demand for medical supplies soars worldwide in the fight against Covid-19, there is a parallel risk of substandard and counterfeit medicines in the global...
News
WuXi AppTec Appoints Dr. David Chang as CEO of...
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announced the appointment of Dr. David Chang as Chief Executive...
News
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based...
Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. announced an expansion of their existing collaboration to provide Regeneron with rights to develop products for additional in...
News
Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as...
Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), announced results from...
News
LabCorp Launches New COVID-19 Clinical Trial Site to Connect...
LabCorp , a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has created...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.